Market Cap (In KRW)
194.53 Billion
Revenue (In KRW)
726.39 Billion
Net Income (In KRW)
5 Billion
Avg. Volume
320.82 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 10120.0-19870.0
- PE
- 53.49
- EPS
- 249.6
- Beta Value
- 1.116
- ISIN
- KR7271980005
- CUSIP
- -
- CIK
- -
- Shares
- 14571545.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Seok-Jae Sung
- Employee Count
- -
- Website
- https://www.jeilpharm.co.kr
- Ipo Date
- 2017-07-18
- Details
- Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.
More Stocks
-
000670Young Poong Corporation
000670
-
CIM
-
MONEYBOXXMONEYBOXX FINANCE LIMITED
MONEYBOXX
-
002787ChinHung International, Inc.
002787
-
5310Toyo Tanso Co., Ltd.
5310
-
1429
-
FRSFORIS AG
FRS
-
FIBI